The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.

Summary

It is intended to examine the safety and efficacy of desensitization therapy by GB-0998 (intravenous immunoglobulin) for the anti-donor antibody positive recipient in need of pre-transplant desensitization. Patients with positive FCXM-T after performing twice double filtration plasmapheresis (DFPP) therapy will receive GB-0998 1g/kg/day for four days.

Timeline

Start

2013-11

Primary completion

2015-09

Completion

2015-09

Drugs

Indications